VCardio Healthcare — Advancing Better Healthcare Partnershipsjvhealthcare0123@gmail.com   |   +91 9876611336
VCardio Product

JEMPAGLIP-M

JEMPAGLIP-M combines Empagliflozin and Metformin to provide complementary blood-glucose-lowering action in appropriate patients with type 2 diabetes.

Product Information

JEMPAGLIP-M

CompositionEmpagliflozin 12.5 mg + Metformin 500 mg
Product TypeTablet
Packaging10 × 10 Blister
MRP₹1,218.75
Product CodeVH-21
DivisionVCardio Healthcare
Enquire About Product →
Detailed Information

Product Details

Information entered in the Product Information panel is displayed here automatically.

Uses & Benefits

Helps improve blood glucose control
Supports insulin-sensitizing therapy
Promotes urinary glucose excretion
Provides complementary mechanisms for diabetes management

Indications

Type 2 diabetes mellitus when combination therapy is considered appropriate by a healthcare professional.

Dosage / How to Use

Take strictly according to the physician's prescription. Follow the prescribed relationship with meals and maintain adequate hydration.

Side Effects

Nausea, diarrhea, abdominal discomfort, increased urination, genital fungal infections, urinary infections and dehydration may occur.

Storage

Store in a cool, dry place away from direct sunlight, heat and moisture.

Prescription / Warning

Prescription medicine. Kidney function and individual clinical factors should be considered before and during treatment.
VCardio Healthcare

Need product information or a business enquiry?

Contact the VCardio Healthcare team for product, distribution and partnership enquiries.

Contact Us →